Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results

Tekijä Sormani, M, Molyneux, P, Gasperini, C, Barkhof, F, Yousry, T, Miller, D, Filippi, M
Julkaistu 1999

Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality

Tekijä Di Battista, G., Bertolotto, A., Gasperini, C., Ghezzi, A., Maimone, D., Solaro, C.
Julkaistu 2014

Home based management in multiple sclerosis: results of a randomised controlled trial

Tekijä Pozzilli, C, Brunetti, M, Amicosante, A, Gasperini, C, Ristori, G, Palmisano, L, Battaglia, M
Julkaistu 2002

Patients with clinically definite multiple sclerosis, white matter abnormalities on MRI, and normal CSF: if not multiple sclerosis, what is it?

Tekijä Fieschi, C, Gasperini, C, Ristori, G, Bastianello, S, Girmenia, F, Leuzzi, V, Buttinelli, C, Rasura, M
Julkaistu 1995

Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.

Tekijä Koudriavtseva, T, Thompson, A J, Fiorelli, M, Gasperini, C, Bastianello, S, Bozzao, A, Paolillo, A, Pisani, A, Galgani, S, Pozzilli, C
Julkaistu 1997

Interferon-β-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images

Tekijä Gasperini, C., Pozzilli, C., Bastianello, S., Giugni, E., Horsfield, M., Koudriavtseva, T., Galgani, S., Paolillo, A., Haggiag, S., Millefiorini, E., Fieschi, C.
Julkaistu 1999

A controlled study of potential risk factors preceding exacerbation in multiple sclerosis.

Tekijä Gasperini, C, Grasso, M G, Fiorelli, M, Millefiorini, E, Morino, S, Anzini, A, Colleluori, A, Salvetti, M, Buttinelli, C, Pozzilli, C
Julkaistu 1995

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

Tekijä Pozzilli, C, Bastianello, S, Koudriavtseva, T, Gasperini, C, Bozzao, A, Millefiorini, E, Galgani, S, Buttinelli, C, Perciaccante, G, Piazza, G, Bozzao, L, Fieschi, C
Julkaistu 1996

Interferon β treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology

Tekijä Filippi, M, Rovaris, M, Capra, R, Gasperini, C, Prandini, F, Martinelli, V, Horsfield, M, Bastianello, S, Sormani, M, Pozzilli, C, Comi, G
Julkaistu 1999

Tailored Vessel-Catheter Diameter Ratio in a Direct Aspiration First-Pass Technique: Is It a Matter of Caliber?

Tekijä Pampana, E., Fabiano, S., De Rubeis, G., Bertaccini, L., Stasolla, A., Vallone, A., Pingi, A., Mangiardi, M., Anticoli, S., Gasperini, C., Cotroneo, E.
Julkaisussa AJNR Am J Neuroradiol (2021)

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

Tekijä Cencioni, M T, Santini, S, Ruocco, G, Borsellino, G, De Bardi, M, Grasso, M G, Ruggieri, S, Gasperini, C, Centonze, D, Barilá, D, Battistini, L, Volpe, E
Julkaisussa Cell Death Dis (2015)

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

Tekijä Cencioni, M T, Santini, S, Ruocco, G, Borsellino, G, De Bardi, M, Grasso, M G, Ruggieri, S, Gasperini, C, Centonze, D, Barilá, D, Battistini, L, Volpe, E
Julkaisussa Cell Death Dis (2015)

MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES

Tekijä Filippi, M., Rocca, M.A., Ciccarelli, O., De Stefano, N., Evangelou, N., Kappos, L., Rovira, A., Sastre-Garriga, J., Tintorè, M., Frederiksen, J.L., Gasperini, C., Palace, J., Reich, D.S., Banwell, B., Montalban, X., Barkhof, F.
Julkaisussa Lancet Neurol (2016)

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

Tekijä Kearney, H, Rocca, MA, Valsasina, P, Balk, L, Sastre-Garriga, J, Reinhardt, J, Ruggieri, S, Rovira, A, Stippich, C, Kappos, L, Sprenger, T, Tortorella, P, Rovaris, M, Gasperini, C, Montalban, X, Geurts, JJG, Polman, CH, Barkhof, F, Filippi, M, Altmann, DR, Ciccarelli, O, Miller, DH, Chard, DT
Julkaistu 2014

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

Tekijä Patti, F, Messina, S, Solaro, C, Amato, M P, Bergamaschi, R, Bonavita, S, Bruno Bossio, R, Brescia Morra, V, Costantino, G F, Cavalla, P, Centonze, D, Comi, G, Cottone, S, Danni, M, Francia, A, Gajofatto, A, Gasperini, C, Ghezzi, A, Iudice, A, Lus, G, Maniscalco, G T, Marrosu, M G, Matta, M, Mirabella, M, Montanari, E, Pozzilli, C, Rovaris, M, Sessa, E, Spitaleri, D, Trojano, M, Valentino, P, Zappia, M
Julkaisussa J Neurol Neurosurg Psychiatry (2016)